Kipp Weiskopf

Affiliations: 
Whitehead Institute for Biomedical Research (MIT) 
Area:
Cancer Immunotherapy
Google:
"Kipp Weiskopf"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vaccaro K, Allen J, Whitfield TW, et al. (2024) Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. The Journal of Clinical Investigation
Vaccaro K, Allen J, Whitfield TW, et al. (2023) Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction. Biorxiv : the Preprint Server For Biology
Anderson KL, Snyder KM, Ito D, et al. (2019) Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade. Melanoma Research
Kohrt HE, Colevas AD, Houot R, et al. (2019) Targeting CD137 enhances the efficacy of cetuximab. The Journal of Clinical Investigation. 129: 2595
Kohrt HE, Houot R, Weiskopf K, et al. (2019) Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer. The Journal of Clinical Investigation. 129: 2595
Anderson KL, Snyder KM, Ito D, et al. (2019) Abstract A051: Melanoma displays an evolutionarily conserved resistance to upregulation of prophagocytic signals and to CD47 blockade Cancer Immunology Research. 7
Barkal AA, Weiskopf K, Kao KS, et al. (2018) Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nature Immunology. 19: 76-84
Ring NG, Herndler-Brandstetter D, Weiskopf K, et al. (2017) Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. Proceedings of the National Academy of Sciences of the United States of America
Hu MS, Walmsley GG, Barnes LA, et al. (2017) Delivery of monocyte lineage cells in a biomimetic scaffold enhances tissue repair. Jci Insight. 2
Weiskopf K. (2017) Cancer immunotherapy targeting the CD47/SIRPα axis. European Journal of Cancer (Oxford, England : 1990). 76: 100-109
See more...